Portfolio company
Excelsior Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops a chemistry platform using modular building blocks to automate the discovery and manufacture of small molecules for pharmaceutical and materials science customers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Chemify
This company provides automated molecular design and synthesis services to pharmaceutical, biotechnology and industrial partners using robotics and artificial intelligence.
b-12
This company develops an artificial intelligence platform to automate chemical synthesis and laboratory experiments for pharmaceutical and biotechnology researchers.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Lila Sciences
This company develops an autonomous discovery platform and robotic laboratories for customers in the medicine, materials science, energy, and semiconductor industries.
Solve Chemistry
This company provides an automated laboratory platform and predictive software to optimise chemical process development for pharmaceutical, agrochemical and specialty chemical customers.
AI-DRIVEN CHEMISTRY
This company provides a machine learning platform to help pharmaceutical and chemical organisations accelerate research and development by optimizing experiments using small datasets.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
